The Guardian (Asia Pacific)

Daily pill can double survival time for world’s deadliest cancer, trial shows

31 mai 2026 | Andrew Gregory in Chicago

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)

Article original.

Site référencé: The Guardian (Asia Pacific)

3944.jpg?width=140&quality=85&auto=format&fit=max&s=3b43846a257ff075508ffce8a1f47d39, 3944.jpg?width=460&quality=85&auto=format&fit=max&s=7cc9fbebcd71e89831ebf650f0cbb809, 3944.jpg?width=700&quality=85&auto=format&fit=max&s=3205c77dea48b719949e7d6320e5d2ce